Filed: 5/14/2024ACC: 0001766721-24-000003
📋 What this filing means
AISLING CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 16 equity positions with a total reported market value of $295.50M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
16
Positions
$295.50M
Total AUM (reported)
22.52M
Total Shares
Allocation by class
COM$258.93M87.6%
SPONSORED ADS$25.97M8.8%
COM CL A$9.25M3.1%
COM NEW$1.35M0.5%
Portfolio Concentration
Top 3$229.97M77.8%
4–10$59.63M20.2%
11–25$5.90M2.0%
Top 3 weight
77.8%
Top 10 weight
98.0%
Voting Authority Distribution
Total shares with voting rights: 22.52M
Sole
Full voting authority
22.52M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole16
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings16
Rows:
BridgeBio Pharma Inc. (BBIO)
SOLEShares6.07M
TypeSH
Market value$187.63M
63.50%
Sole
6.07M
Shared
0.00
None
0.00
Syndax Pharmaceuticals, Inc. (SNDX)
SOLEShares1.02M
TypeSH
Market value$24.39M
8.26%
Sole
1.02M
Shared
0.00
None
0.00
Verona Pharma plc (VRNA)
SOLEShares1.12M
TypeSH
Market value$17.95M
6.07%
Sole
1.12M
Shared
0.00
None
0.00
Elevation Oncology Inc (ELEV)
SOLEShares2.83M
TypeSH
Market value$14.54M
4.92%
Sole
2.83M
Shared
0.00
None
0.00
Biomea Fusion Inc (BMEA)
SOLEShares798.76K
TypeSH
Market value$11.94M
4.04%
Sole
798.76K
Shared
0.00
None
0.00
Monte Rosa Therapeutics Inc (GLUE)
SOLEShares1.47M
TypeSH
Market value$10.38M
3.51%
Sole
1.47M
Shared
0.00
None
0.00
Nuvation Bio Inc. (NUVB)
SOLEShares2.54M
TypeSH
Market value$9.25M
3.13%
Sole
2.54M
Shared
0.00
None
0.00
Compass Pathways Plc (CMPS)
SOLEShares964.50K
TypeSH
Market value$8.02M
2.72%
Sole
964.50K
Shared
0.00
None
0.00
Poseida Therapeutics Inc. (PSTX)
SOLEShares1.04M
TypeSH
Market value$3.33M
1.13%
Sole
1.04M
Shared
0.00
None
0.00
CalciMedica, Inc. (CALC)
SOLEShares521.11K
TypeSH
Market value$2.17M
0.73%
Sole
521.11K
Shared
0.00
None
0.00
Reneo Pharmaceuticals Inc (RPHM)
SOLEShares886.08K
TypeSH
Market value$1.47M
0.50%
Sole
886.08K
Shared
0.00
None
0.00
Marker Therapeutics, Inc. (MRKR)
SOLEShares314.29K
TypeSH
Market value$1.35M
0.46%
Sole
314.29K
Shared
0.00
None
0.00
Avrobio, Inc. (AVRO)
SOLEShares1.01M
TypeSH
Market value$1.29M
0.44%
Sole
1.01M
Shared
0.00
None
0.00
Spruce Biosciences, Inc. (SPRB)
SOLEShares1.21M
TypeSH
Market value$947.5K
0.32%
Sole
1.21M
Shared
0.00
None
0.00
Aclaris Therapeutics Inc (ACRS)
SOLEShares434.45K
TypeSH
Market value$538.7K
0.18%
Sole
434.45K
Shared
0.00
None
0.00
Viracta Therapeutics Inc (VIRX)
SOLEShares288.57K
TypeSH
Market value$294.3K
0.10%
Sole
288.57K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BridgeBio Pharma Inc. (BBIO)SOLE | COM | 6.07M | SH | $187.63M 63.50% | 6.07M | 0.00 | 0.00 |
Syndax Pharmaceuticals, Inc. (SNDX)SOLE | COM | 1.02M | SH | $24.39M 8.26% | 1.02M | 0.00 | 0.00 |
Verona Pharma plc (VRNA)SOLE | SPONSORED ADS | 1.12M | SH | $17.95M 6.07% | 1.12M | 0.00 | 0.00 |
Elevation Oncology Inc (ELEV)SOLE | COM | 2.83M | SH | $14.54M 4.92% | 2.83M | 0.00 | 0.00 |
Biomea Fusion Inc (BMEA)SOLE | COM | 798.76K | SH | $11.94M 4.04% | 798.76K | 0.00 | 0.00 |
Monte Rosa Therapeutics Inc (GLUE)SOLE | COM | 1.47M | SH | $10.38M 3.51% | 1.47M | 0.00 | 0.00 |
Nuvation Bio Inc. (NUVB)SOLE | COM CL A | 2.54M | SH | $9.25M 3.13% | 2.54M | 0.00 | 0.00 |
Compass Pathways Plc (CMPS)SOLE | SPONSORED ADS | 964.50K | SH | $8.02M 2.72% | 964.50K | 0.00 | 0.00 |
Poseida Therapeutics Inc. (PSTX)SOLE | COM | 1.04M | SH | $3.33M 1.13% | 1.04M | 0.00 | 0.00 |
CalciMedica, Inc. (CALC)SOLE | COM | 521.11K | SH | $2.17M 0.73% | 521.11K | 0.00 | 0.00 |
Reneo Pharmaceuticals Inc (RPHM)SOLE | COM | 886.08K | SH | $1.47M 0.50% | 886.08K | 0.00 | 0.00 |
Marker Therapeutics, Inc. (MRKR)SOLE | COM NEW | 314.29K | SH | $1.35M 0.46% | 314.29K | 0.00 | 0.00 |
Avrobio, Inc. (AVRO)SOLE | COM | 1.01M | SH | $1.29M 0.44% | 1.01M | 0.00 | 0.00 |
Spruce Biosciences, Inc. (SPRB)SOLE | COM | 1.21M | SH | $947.5K 0.32% | 1.21M | 0.00 | 0.00 |
Aclaris Therapeutics Inc (ACRS)SOLE | COM | 434.45K | SH | $538.7K 0.18% | 434.45K | 0.00 | 0.00 |
Viracta Therapeutics Inc (VIRX)SOLE | COM | 288.57K | SH | $294.3K 0.10% | 288.57K | 0.00 | 0.00 |